Number of responders ‐ mild to moderate disease (12 weeks) · IBD patients
IV ferric carboxymaltose showed no clear difference in number of responders ‐ mild to moderate disease (16 weeks) compared with oral iron sulphate (low certainty).
1 finding from 1 review
Serious adverse events ‐ mild to moderate disease (16 weeks) · IBD patients
It is very uncertain whether IV ferric carboxymaltose changes serious adverse events ‐ mild to moderate disease (16 weeks) compared with oral iron sulphate (very low certainty).
1 finding from 1 review
Number of responders ‐ mild to moderate disease (12 weeks) · IBD patients
IV ferric carboxymaltose probably leads to higher number of responders ‐ mild to moderate disease (12 weeks) compared with IV iron sucrose (moderate certainty).
1 finding from 1 review
Serious adverse events ‐ mild to moderate disease (12 weeks) · IBD patients
It is very uncertain whether IV ferric carboxymaltose changes serious adverse events ‐ mild to moderate disease (12 weeks) compared with IV iron sucrose (very low certainty).
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
It is very uncertain whether fibre‐enriched enteral nutrition changes all‐cause mortality compared with control (very low certainty).
1 finding from 1 review
Systemic inflammatory response syndrome · patients with acute pancreatitis
It is very uncertain whether fibre‐enriched enteral nutrition changes systemic inflammatory response syndrome compared with control (very low certainty).
1 finding from 1 review
Organ failure · patients with acute pancreatitis
It is very uncertain whether fibre‐enriched enteral nutrition changes organ failure compared with control (very low certainty).
1 finding from 1 review
Adverse events ‐ not reported · patients with acute pancreatitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment success as defined by the authors · people with Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Abdominal pain frequency or change in frequency · people with Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Abdominal pain intensity or change in intensity · people with Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · people with Crohn's disease
It is very uncertain whether enteric‐release glyceryl trinitrate changes withdrawal due to adverse events compared with placebo (very low certainty).
1 finding from 1 review
Endoscopic metrics ‐ not measured · GORD in infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Endoscopic metrics ‐ not measured · GORD in children over 1 year of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement in pH metrics in infants · GORD in infants
1 finding from 1 review
Endoscopic metrics ‐ not measured · GORD in infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement in pH metrics in infants ‐ not measured · GORD in infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Visualisation of gastric mucosa · people with acute UGIH
1 finding from 1 review
Intervention not reported
Delayed gastric emptying (all definitions) · adults with any pancreatic diagnosis leading to an indication for elective (classical, pylorus‐preserving, pylorus‐resecting) partial…
The intervention showed no clear difference in delayed gastric emptying (all definitions) (low certainty).
1 finding from 1 review
Remission · Patients with active Crohn's disease
It is very uncertain whether intervention diet changes induction of remission at 6 weeks ‐ Highly restricted, organic diet compared with control diet (very low certainty).
1 finding from 1 review